| Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline SH Armenian, C Lacchetti, A Barac, J Carver, LS Constine, N Denduluri, ... J Clin Oncol 35 (8), 893-911, 2017 | 1233 | 2017 |
| Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL RA Shivdasani, EL Mayer, SH Orkin Nature 373 (6513), 432-434, 1995 | 1174 | 1995 |
| Patient adherence and persistence with oral anticancer treatment K Ruddy, E Mayer, A Partridge CA: a cancer journal for clinicians 59 (1), 56-66, 2009 | 753 | 2009 |
| TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer LA Carey, HS Rugo, PK Marcom, EL Mayer, FJ Esteva, CX Ma, MC Liu, ... Journal of clinical oncology 30 (21), 2615, 2012 | 607 | 2012 |
| Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer AH Partridge, A LaFountain, E Mayer, BS Taylor, E Winer, ... Journal of Clinical Oncology 26 (4), 556-562, 2008 | 555 | 2008 |
| TBCRC009: a multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer SJ Isakoff, EL Mayer, L He, TA Traina, LA Carey, KJ Krag, HS Rugo, ... Journal of clinical oncology 33 (17), 1902, 2015 | 471 | 2015 |
| Congestive heart failure risk in patients with breast cancer treated with bevacizumab TK Choueiri, EL Mayer, Y Je, JE Rosenberg, PL Nguyen, GR Azzi, ... Journal of Clinical Oncology 29 (6), 632-638, 2011 | 335 | 2011 |
| Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level A Barac, G Murtagh, JR Carver, MH Chen, AM Freeman, J Herrmann, ... Journal of the American College of Cardiology 65 (25), 2739-2746, 2015 | 258 | 2015 |
| Clinical cancer advances 2016: annual report on progress against cancer from the American Society of Clinical Oncology DS Dizon, L Krilov, E Cohen, T Gangadhar, PA Ganz, TA Hensing, ... Journal of clinical oncology: official journal of the American Society of …, 2016 | 239 | 2016 |
| Randomized phase III trial of paclitaxel once per week compared with nanoparticle albumin-bound nab-paclitaxel once per week or ixabepilone with bevacizumab as first-line … HS Rugo, WT Barry, A Moreno-Aspitia, AP Lyss, C Cirrincione, E Leung, ... Journal of Clinical Oncology 33 (21), 2361, 2015 | 228 | 2015 |
| Advances in targeting SRC in the treatment of breast cancer and other solid malignancies EL Mayer, IE Krop Clinical Cancer Research 16 (14), 3526-3532, 2010 | 228 | 2010 |
| Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study EL Mayer, AC Dueck, M Martin, G Rubovszky, HJ Burstein, ... The lancet oncology 22 (2), 212-222, 2021 | 226 | 2021 |
| Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial PA Konstantinopoulos, WT Barry, M Birrer, SN Westin, KA Cadoo, ... The Lancet Oncology 20 (4), 570-580, 2019 | 214 | 2019 |
| Cardiac toxicity from systemic cancer therapy: a comprehensive review G Curigliano, EL Mayer, HJ Burstein, EP Winer, A Goldhirsch Progress in cardiovascular diseases 53 (2), 94-104, 2010 | 193 | 2010 |
| Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update F Andre, N Ismaila, KH Allison, WE Barlow, DE Collyar, S Damodaran, ... Journal of Clinical Oncology 40 (16), 1816-1837, 2022 | 183 | 2022 |
| Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel AS Becker, R Perez-Johnston, SA Chikarmane, MM Chen, M El Homsi, ... Radiology 300 (2), E323-E327, 2021 | 151 | 2021 |
| Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer HA Parsons, J Rhoades, SC Reed, G Gydush, P Ram, P Exman, K Xiong, ... Clinical Cancer Research 26 (11), 2556-2564, 2020 | 131 | 2020 |
| A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): responses and … B Jovanović, IA Mayer, EL Mayer, VG Abramson, A Bardia, ME Sanders, ... Clinical Cancer Research 23 (15), 4035-4045, 2017 | 129 | 2017 |
| Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors ML Irwin, B Cartmel, M Harrigan, F Li, T Sanft, L Shockro, K O'Connor, ... Cancer 123 (7), 1249-1258, 2017 | 123 | 2017 |
| A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer EL Mayer, JF Baurain, J Sparano, L Strauss, M Campone, P Fumoleau, ... Clinical cancer research 17 (21), 6897-6904, 2011 | 122 | 2011 |
